Tango Therapeutics, Inc. financial data

Symbol
TNGX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 638% % -18%
Debt-to-equity 57% % 3.6%
Return On Equity -61% % -23%
Return On Assets -39% % -21%
Operating Margin -166% % 48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 134,593,998 shares 25%
Common Stock, Shares, Outstanding 111,567,062 shares 3.9%
Entity Public Float $855,100,000 USD 382%
Common Stock, Value, Issued $112,000 USD 4.7%
Weighted Average Number of Shares Outstanding, Basic 110,966,345 shares 2.3%
Weighted Average Number of Shares Outstanding, Diluted 117,782,074 shares 8.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $66,500,000 USD 53%
Research and Development Expense $134,000,000 USD -5.2%
General and Administrative Expense $42,835,000 USD 2.6%
Operating Income (Loss) $110,335,000 USD 21%
Nonoperating Income (Expense) $9,928,000 USD -40%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $100,407,000 USD 18%
Income Tax Expense (Benefit) $108,000 USD -48%
Net Income (Loss) Attributable to Parent $100,515,000 USD 19%
Earnings Per Share, Basic 0 USD/shares 22%
Earnings Per Share, Diluted 0 USD/shares 22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $58,338,000 USD 9.8%
Marketable Securities, Current $94,473,000 USD -61%
Cash, Cash Equivalents, and Short-term Investments $152,800,000 USD
Assets, Current $163,779,000 USD -46%
Property, Plant and Equipment, Net $7,346,000 USD -14%
Operating Lease, Right-of-Use Asset $36,582,000 USD -9.5%
Other Assets, Noncurrent $290,000 USD 2131%
Assets $210,136,000 USD -40%
Accounts Payable, Current $2,229,000 USD -46%
Employee-related Liabilities, Current $6,477,000 USD -0.45%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $18,444,000 USD -51%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $31,661,000 USD -8.9%
Liabilities $50,105,000 USD -59%
Accumulated Other Comprehensive Income (Loss), Net of Tax $121,000 USD -84%
Retained Earnings (Accumulated Deficit) $564,403,000 USD -22%
Stockholders' Equity Attributable to Parent $160,031,000 USD -30%
Liabilities and Equity $210,136,000 USD -40%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $41,697,000 USD -10%
Net Cash Provided by (Used in) Financing Activities $42,982,000 USD
Net Cash Provided by (Used in) Investing Activities $30,597,000 USD
Common Stock, Shares Authorized 400,000,000 shares 100%
Common Stock, Shares, Issued 111,567,062 shares 3.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,098,000 USD -83%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $60,905,000 USD 9.3%
Deferred Tax Assets, Valuation Allowance $156,402,000 USD 38%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $168,852,000 USD 33%
Depreciation $622,000 USD -0.48%
Payments to Acquire Property, Plant, and Equipment $51,000 USD -74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $101,144,000 USD 17%
Property, Plant and Equipment, Gross $17,406,000 USD 6.6%
Operating Lease, Liability, Current $3,102,000 USD 8.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $30,640,000 USD 85%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $724,201,000 USD 4.6%
Deferred Tax Assets, Net of Valuation Allowance $12,450,000 USD -11%
Share-based Payment Arrangement, Expense $27,912,000 USD 6.1%